Page 54 - Demo

Case 5: Cytomegalovirus (CMV) Retinitis Management%u2022 Initiate anti-CMV therapy:%u2022 Induction: Intravenous ganciclovir or foscarnet for 2-3 weeks%u2022 Maintenance: Oral valganciclovir%u2022 Consider intravitreal ganciclovir injections for rapid local control%u2022 Optimize antiretroviral therapy to improve immune function%u2022 Monitor CD4 count and HIV viral load%u2022 Regular ophthalmological follow-ups to assess treatment response and detect progression%u2022 Continue maintenance therapy until immune reconstitution (CD4 > 100 cells/%u03bcL for at least 3-6 months)%u2022 Educate patient on importance of adherence to both anti-CMV and antiretroviral medications%u2022 Consider prophylaxis for the unaffected eye